Analyze Diet
Journal of equine veterinary science2020; 88; 102942; doi: 10.1016/j.jevs.2020.102942

Detection and Pharmacokinetics of Etoricoxib in Thoroughbred Horses.

Abstract: Etoricoxib, a selective inhibitor of cyclooxygenase-2, is used in the treatment of many inflammatory diseases and dental pain in humans. The aim of this study was to determine the pharmacokinetics and metabolism of etoricoxib in horses. Six horses weighing an average of 475 ± 25 kg were administered a single oral dose of etoricoxib at 1 mg/kg body weight. The results show that the drug reached a maximum concentration of 505.2 ± 67.8 ng/mL in 48 minutes after administration. The elimination half-life was calculated to be 10.20 ± 1.30 hours. Mass spectrometric analysis confirmed that etoricoxib is metabolized in horses via the oxidation of its 6'-methyl group to form a hydroxyl methyl etoricoxib which can further be oxidized to form either an acid or be glucuronidated. In addition, the 1'-N terminal of 6'-hydroxymethyl metabolite is oxidized to form the corresponding 1'-N oxide metabolite. The present results have clearly demonstrated that etoricoxib is mainly excreted in urine as metabolites. From these data, it is also possible to postulate a detection time for the metabolites which in turn can assist in the control of illegal use of the drug in horse racing.
Publication Date: 2020-02-01 PubMed ID: 32303303DOI: 10.1016/j.jevs.2020.102942Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses a study that investigates how the drug etoricoxib, usually used for treating inflammation and dental pain in humans, is metabolized in horses. Further, the study also aimed to determine the time taken for the drug to be entirely eliminated from the horse’s body, providing data that could help curb its illegal use in horse racing.

Pharmacokinetics of Etoricoxib

  • The study was carried out on six Thoroughbred horses, each weighing an average of 475 ± 25 kg. These horses were given a one-time oral dose of etoricoxib, calibrated at 1 mg/kg body weight.
  • The pharmacokinetics of the drug revealed that it reached its maximum concentration, about 505.2 ± 67.8 ng/mL, in the horse’s system approximately 48 minutes post administration.
  • The elimination half-life of the drug, i.e., the time taken for the drug’s concentration to reduce by half in the body, was calculated to be 10.20 ± 1.30 hours. This period indicates how long the drug remains in the horse’s system.

Drug’s Metabolism and Excretion

  • Mass spectrometric analysis was employed to confirm the metabolic pathway of etoricoxib in horses.
  • The analysis showed that etoricoxib is metabolized via oxidation of its 6′-methyl group to form hydroxyl methyl etoricoxib. This metabolite may undergo further oxidation to produce an acid or undergo glucuronidation, a process where the drug molecules link with glucuronic acid for easy excretion.
  • The study also found out that the 1′-N terminal of the 6′-hydroxymethyl metabolite is oxidized to a 1′-N oxide metabolite.
  • Etoricoxib was primarily found to be excreted in urine in the form of its metabolites.

Implications for Horse Racing

  • The data collected from this study can be used to estimate a detection window for etoricoxib and its metabolites in horses’ systems. This information is crucial in setting up guidelines and controls to detect illegal use of the drug in horse racing.
  • Detecting the presence of etoricoxib helps maintain the integrity of horse racing and ensures a level playing field for all competitors.

Cite This Article

APA
Subhahar MB, Singh J, Albert PH, Kadry AM. (2020). Detection and Pharmacokinetics of Etoricoxib in Thoroughbred Horses. J Equine Vet Sci, 88, 102942. https://doi.org/10.1016/j.jevs.2020.102942

Publication

ISSN: 0737-0806
NlmUniqueID: 8216840
Country: United States
Language: English
Volume: 88
Pages: 102942
PII: S0737-0806(20)30033-2

Researcher Affiliations

Subhahar, Michael B
  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.
Singh, Jaipaul
  • School of Forensic and Applied Sciences, College of Science and Technology, University of Central Lancashire, Preston, UK.
Albert, Peter H
  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.
Kadry, Ahmed M
  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates. Electronic address: akadry@cfldubai.ae.

MeSH Terms

  • Animals
  • Area Under Curve
  • Body Fluids
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Etoricoxib
  • Horses

Citations

This article has been cited 0 times.